Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

CVS Health Corp. (NYSE:CVS)

Common Stock Valuation Ratios (Price Multiples)

Beginner level

Valuation ratios measure the quantity of an asset or flaw (e.g., earnings) associated with ownership of a specified claim (e.g., a share of ownership of the enterprise).


Current Valuation Ratios

CVS Health Corp., current price multiples

Microsoft Excel LibreOffice Calc
CVS Health Corp. Walgreens Boots Alliance Inc. Food & Drug Retailers Consumer Services
Selected Financial Data
Current share price (P) $64.70
No. shares of common stock outstanding 1,307,090,830
Growth rate (g) 7.15%
 
Earnings per share (EPS) $5.08
Next year expected EPS $5.44
Operating profit per share $9.17
Sales per share $195.68
Book value per share (BVPS) $48.86
Valuation Ratios (Price Multiples)
Price to earnings (P/E) 12.75 9.25 11.44 37.24
Price to next year expected earnings 11.90 8.46 10.58 32.80
Price-earnings-growth (PEG) 1.78 0.99 1.42 2.75
Price to operating profit (P/OP) 7.06 7.37 7.15 24.14
Price to sales (P/S) 0.33 0.27 0.31 1.82
Price to book value (P/BV) 1.32 1.57 1.39 7.68

Based on: 10-K (filing date: 2020-02-18).

If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.
Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.


Historical Valuation Ratios (Summary)

CVS Health Corp., historical price multiples

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Price to earnings (P/E) 14.15 10.69 14.91 18.98
Price to operating profit (P/OP) 7.83 18.65 7.44 7.65 10.49
Price to sales (P/S) 0.37 0.39 0.38 0.45 0.65
Price to book value (P/BV) 1.47 1.29 1.88 2.15 2.67

Based on: 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-14), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-09).

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. CVS Health Corp.’s P/E ratio decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. CVS Health Corp.’s P/OP ratio increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. CVS Health Corp.’s P/S ratio increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return. CVS Health Corp.’s P/BV ratio decreased from 2017 to 2018 but then slightly increased from 2018 to 2019.

Price to Earnings (P/E)

CVS Health Corp., historical P/E calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
No. shares of common stock outstanding1 1,304,159,680 1,297,082,165 1,014,532,157 1,025,699,605 1,098,490,835
Selected Financial Data (US$)
Net income (loss) attributable to CVS Health (in millions) 6,634  (594) 6,622  5,317  5,237 
Earnings per share (EPS)2 5.09 -0.46 6.53 5.18 4.77
Share price1, 3 72.00 57.83 69.79 77.31 90.51
Valuation Ratio
P/E ratio4 14.15 10.69 14.91 18.98
Benchmarks
P/E Ratio, Competitors5
Walgreens Boots Alliance Inc. 12.51 13.39 17.17 21.03 21.92
P/E Ratio, Sector
Food & Drug Retailers 13.54 32.12 13.16 17.60 20.29
P/E Ratio, Industry
Consumer Services 31.72 29.01 23.41 25.44 27.27

Based on: 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-14), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-09).

1 Data adjusted for splits and stock dividends.

2 2019 Calculation
EPS = Net income (loss) attributable to CVS Health ÷ No. shares of common stock outstanding
= 6,634,000,000 ÷ 1,304,159,680 = 5.09

3 Closing price as at the filing date of CVS Health Corp.’s Annual Report.

4 2019 Calculation
P/E ratio = Share price ÷ EPS
= 72.00 ÷ 5.09 = 14.15

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. CVS Health Corp.’s P/E ratio decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.

Price to Operating Profit (P/OP)

CVS Health Corp., historical P/OP calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
No. shares of common stock outstanding1 1,304,159,680 1,297,082,165 1,014,532,157 1,025,699,605 1,098,490,835
Selected Financial Data (US$)
Operating income (in millions) 11,987  4,021  9,517  10,366  9,475 
Operating profit per share2 9.19 3.10 9.38 10.11 8.63
Share price1, 3 72.00 57.83 69.79 77.31 90.51
Valuation Ratio
P/OP ratio4 7.83 18.65 7.44 7.65 10.49
Benchmarks
P/OP Ratio, Competitors5
Walgreens Boots Alliance Inc. 9.96 10.49 12.60 14.63 19.81
P/OP Ratio, Sector
Food & Drug Retailers 8.46 13.64 9.34 10.21 13.57
P/OP Ratio, Industry
Consumer Services 20.56 18.48 17.84 15.62 15.33

Based on: 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-14), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-09).

1 Data adjusted for splits and stock dividends.

2 2019 Calculation
Operating profit per share = Operating income ÷ No. shares of common stock outstanding
= 11,987,000,000 ÷ 1,304,159,680 = 9.19

3 Closing price as at the filing date of CVS Health Corp.’s Annual Report.

4 2019 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 72.00 ÷ 9.19 = 7.83

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. CVS Health Corp.’s P/OP ratio increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.

Price to Sales (P/S)

CVS Health Corp., historical P/S calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
No. shares of common stock outstanding1 1,304,159,680 1,297,082,165 1,014,532,157 1,025,699,605 1,098,490,835
Selected Financial Data (US$)
Revenues from customers (in millions) 255,765  193,919  184,765  177,526  153,290 
Sales per share2 196.11 149.50 182.12 173.08 139.55
Share price1, 3 72.00 57.83 69.79 77.31 90.51
Valuation Ratio
P/S ratio4 0.37 0.39 0.38 0.45 0.65
Benchmarks
P/S Ratio, Competitors5
Walgreens Boots Alliance Inc. 0.36 0.51 0.59 0.75 0.89
P/S Ratio, Sector
Food & Drug Retailers 0.37 0.44 0.46 0.57 0.75
P/S Ratio, Industry
Consumer Services 1.55 1.44 1.44 1.28 1.26

Based on: 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-14), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-09).

1 Data adjusted for splits and stock dividends.

2 2019 Calculation
Sales per share = Revenues from customers ÷ No. shares of common stock outstanding
= 255,765,000,000 ÷ 1,304,159,680 = 196.11

3 Closing price as at the filing date of CVS Health Corp.’s Annual Report.

4 2019 Calculation
P/S ratio = Share price ÷ Sales per share
= 72.00 ÷ 196.11 = 0.37

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. CVS Health Corp.’s P/S ratio increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.

Price to Book Value (P/BV)

CVS Health Corp., historical P/BV calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
No. shares of common stock outstanding1 1,304,159,680 1,297,082,165 1,014,532,157 1,025,699,605 1,098,490,835
Selected Financial Data (US$)
Total CVS Health shareholders’ equity (in millions) 63,864  58,225  37,691  36,830  37,196 
Book value per share (BVPS)2 48.97 44.89 37.15 35.91 33.86
Share price1, 3 72.00 57.83 69.79 77.31 90.51
Valuation Ratio
P/BV ratio4 1.47 1.29 1.88 2.15 2.67
Benchmarks
P/BV Ratio, Competitors5
Walgreens Boots Alliance Inc. 2.12 2.59 2.55 2.94 3.00
P/BV Ratio, Sector
Food & Drug Retailers 1.64 1.69 2.16 2.50 2.82
P/BV Ratio, Industry
Consumer Services 6.54 6.15 6.17 5.29 5.31

Based on: 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-14), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-09).

1 Data adjusted for splits and stock dividends.

2 2019 Calculation
BVPS = Total CVS Health shareholders’ equity ÷ No. shares of common stock outstanding
= 63,864,000,000 ÷ 1,304,159,680 = 48.97

3 Closing price as at the filing date of CVS Health Corp.’s Annual Report.

4 2019 Calculation
P/BV ratio = Share price ÷ BVPS
= 72.00 ÷ 48.97 = 1.47

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return. CVS Health Corp.’s P/BV ratio decreased from 2017 to 2018 but then slightly increased from 2018 to 2019.